Stalevo 75 mg/18.75 mg/200 mg film-coated tablets

Company
Orion Pharma (Ireland) Ltd
Active Ingredient
Dosage Form
Film-coated tablet
Legal Category
B - prescription, may be renewed
Date of revision
01/2022
Licence number Strength ATC Code Dosage Form
EU/1/03/260/24 75/18.75/200 milligram(s) N04BA, N04BA03 Film-coated tablet
EU/1/03/260/25 75/18.75/200 milligram(s) N04BA, N04BA03 Film-coated tablet
EU/1/03/260/26 75/18.75/200 milligram(s) N04BA, N04BA03 Film-coated tablet
EU/1/03/260/27 75/18.75/200 milligram(s) N04BA, N04BA03 Film-coated tablet
EU/1/03/260/28 75/18.75/200 milligram(s) N04BA, N04BA03 Film-coated tablet
Licence number
EU/1/03/260/24
Strength
75/18.75/200 milligram(s)
ATC Code
N04BA, N04BA03
Dosage Form
Film-coated tablet
Licence number
EU/1/03/260/25
Strength
75/18.75/200 milligram(s)
ATC Code
N04BA, N04BA03
Dosage Form
Film-coated tablet
Licence number
EU/1/03/260/26
Strength
75/18.75/200 milligram(s)
ATC Code
N04BA, N04BA03
Dosage Form
Film-coated tablet
Licence number
EU/1/03/260/27
Strength
75/18.75/200 milligram(s)
ATC Code
N04BA, N04BA03
Dosage Form
Film-coated tablet
Licence number
EU/1/03/260/28
Strength
75/18.75/200 milligram(s)
ATC Code
N04BA, N04BA03
Dosage Form
Film-coated tablet

Orion Pharma (Ireland) Ltd

c/o Allphar Services Ltd, 4045 Kingswood Road, Citywest Business Park, Co Dublin D24V06K

Website
https://www.orionpharma.ie
Telephone
+35314688482
Email
ie.medicalinformation@orionpharma.com